GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts
- PMID: 18602406
- DOI: 10.1016/j.neuropharm.2008.06.013
GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts
Abstract
Valerian extracts have been used for centuries to alleviate restlessness and anxiety albeit with unknown mechanism of action in vivo. We now describe a specific binding site on GABA(A) receptors with nM affinity for valerenic acid and valerenol, common constituents of valerian. Both agents enhanced the response to GABA at multiple types of recombinant GABA(A) receptors. A point mutation in the beta2 or beta3 subunit (N265M) of recombinant receptors strongly reduced the drug response. In vivo, valerenic acid and valerenol exerted anxiolytic activity with high potencies in the elevated plus maze and the light/dark choice test in wild type mice. In beta3 (N265M) point-mutated mice the anxiolytic activity of valerenic acid was absent. Thus, neurons expressing beta3 containing GABA(A) receptors are a major cellular substrate for the anxiolytic action of valerian extracts.
Similar articles
-
The anxiolytic effects of a Valerian extract is based on valerenic acid.BMC Complement Altern Med. 2014 Jul 28;14:267. doi: 10.1186/1472-6882-14-267. BMC Complement Altern Med. 2014. PMID: 25066015 Free PMC article.
-
Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity.Neuropharmacology. 2007 Jul;53(1):178-87. doi: 10.1016/j.neuropharm.2007.04.018. Epub 2007 May 13. Neuropharmacology. 2007. PMID: 17585957
-
Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity.Phytomedicine. 2012 Oct 15;19(13):1216-22. doi: 10.1016/j.phymed.2012.08.003. Epub 2012 Sep 1. Phytomedicine. 2012. PMID: 22944521
-
A Review Focused on Molecular Mechanisms of Anxiolytic Effect of Valerina officinalis L. in Connection with Its Phytochemistry through in vitro/in vivo Studies.Curr Pharm Des. 2021;27(28):3084-3090. doi: 10.2174/1381612827666210119105254. Curr Pharm Des. 2021. PMID: 33463459 Review.
-
The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models.Behav Pharmacol. 2001 Nov;12(6-7):451-60. doi: 10.1097/00008877-200111000-00005. Behav Pharmacol. 2001. PMID: 11742138 Review.
Cited by
-
Herbal and Natural Supplements for Improving Sleep: A Literature Review.Psychiatry Investig. 2024 Aug;21(8):810-821. doi: 10.30773/pi.2024.0121. Epub 2024 Aug 2. Psychiatry Investig. 2024. PMID: 39086164 Free PMC article.
-
Natural product-based pharmacological studies for neurological disorders.Front Pharmacol. 2022 Nov 7;13:1011740. doi: 10.3389/fphar.2022.1011740. eCollection 2022. Front Pharmacol. 2022. PMID: 36419628 Free PMC article. Review.
-
The chronic effects of a combination of herbal extracts (Euphytose®) on psychological mood state and response to a laboratory stressor: A randomised, placebo-controlled, double blind study in healthy humans.J Psychopharmacol. 2022 Nov;36(11):1243-1256. doi: 10.1177/02698811221112933. Epub 2022 Jul 23. J Psychopharmacol. 2022. PMID: 35875924 Free PMC article. Clinical Trial.
-
The effects of Valerian on sleep spindles in a model of neuropathic pain.Sleep Sci. 2021 Apr-Jun;14(Spec 2):133-139. doi: 10.5935/1984-0063.20200110. Sleep Sci. 2021. PMID: 35082982 Free PMC article.
-
A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis.Front Psychiatry. 2021 Aug 26;12:583211. doi: 10.3389/fpsyt.2021.583211. eCollection 2021. Front Psychiatry. 2021. PMID: 34512404 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
